Sindhu Ramchandren

9PUBLICATIONS
23CO-AUTHORS
Gene and molecular therapyPacific Peoples and disabilityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Italian languageAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 20, 2026
Evaluation of Sustained Disease Control With Nipocalimab Versus Placebo in the Phase 3 Vivacity-MG3 Study.

|Nov 17, 2025
Validation and Reliability of the Thai Pediatric Charcot-Marie-Tooth Quality of Life Outcome Measure.

Pimchanok Kulsirichawaroj, Arisa Phochaisarn, Sivaporn Limpaninlachat

|Sep 17, 2025
Nipocalimab Dose Selection in Generalized Myasthenia Gravis.

Belén Valenzuela, Martine Neyens, Yaowei Zhu

|Feb 08, 2024
Parent-proxy pediatric CMT quality of life outcome measure: Validation of the Italian version.

Federica Rachele Danti, Emanuela Pagliano, Davide Pareyson

|Jan 02, 2024
Safety and Efficacy of Nipocalimab in Patients With Generalized Myasthenia Gravis: Results From the Randomized Phase 2 Vivacity-MG Study

Carlo Antozzi, Jeffrey Guptill, Vera Bril

|May 11, 2023
Validation of the parent-proxy version of the pediatric Charcot-Marie-Tooth disease quality of life instrument for children aged 0-7 years.

Tong Tong Wu, Richard S Finkel, Carly E Siskind

Pageof 2

Frequent Collaborators

4 joint publications

Michael E Shy

2 joint publications

Davide Pareyson

2 joint publications

Carlo Antozzi

1 joint publications

Vera Fridman